Literature DB >> 6198355

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

J L Cordell, B Falini, W N Erber, A K Ghosh, Z Abdulaziz, S MacDonald, K A Pulford, H Stein, D Y Mason.   

Abstract

A murine monoclonal antibody specific for calf intestinal alkaline phosphatase has been prepared and used in an unlabeled antibody bridge technique for labeling monoclonal antibodies. This procedure--the alkaline phosphatase monoclonal anti-alkaline phosphatase (APAAP) method--gives excellent immunocytochemical labeling of tissue sections and cell smears, comparable in clarity and intensity to that achieved with immunoperoxidase labeling. If the enzyme label is developed with a naphthol salt as a coupling agent and Fast Red or hexazotized new fuchsin as a capture agent, a vivid red reaction product is obtained which is very easily detected by the human eye. For this reason the APAAP technique was found particularly suitable for labeling cell smears (for both cytoplasmic and surface-membrane antigens) and for detecting low numbers of antigen-bearing cells in a specimen (e.g., carcinoma cells in a malignant effusion). It was found possible to enhance the intensity of the APAAP labeling reaction substantially by repeating the second and third incubation steps (i.e., the unlabelled "bridge" antibody and APAAP complexes). The APAAP technique was superior to immunoperoxidase labeling for staining tissues rich in endogenous peroxidase, and could be used in conjunction with immunoperoxidase methods for double immunoenzymatic staining. The method was also applicable to the detection of antigenic molecules following their electrophoretic transfer from SDS-polyacrylamide gels to nitrocellulose sheets ("immunoblotting").

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198355     DOI: 10.1177/32.2.6198355

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  711 in total

1.  Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.

Authors:  C Auw-Haedrich; S E Coupland; A Kapp; A Schmitt-Gräff; R Buchen; H Witschel
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.

Authors:  E Berti; D Tomasini; M H Vermeer; C J Meijer; E Alessi; R Willemze
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  The internalization time course of a given lipopolysaccharide chemotype does not correspond to its activation kinetics in monocytes.

Authors:  A Lentschat; V T El-Samalouti; J Schletter; S Kusumoto; L Brade; E T Rietschel; J Gerdes; M Ernst; H Flad; A J Ulmer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.

Authors:  Andras Komocsi; Peter Lamprecht; Elena Csernok; Antje Mueller; Konstanze Holl-Ulrich; Ulrike Seitzer; Frank Moosig; Armin Schnabel; Wolfgang Ludwig Gross
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Multivisceral intestinal transplantation: surgical pathology.

Authors:  R Jaffe; J D Trager; A Zeevi; E Sonmez-Alpan; R Duquesnoy; S Todo; M Rowe; T E Starzl
Journal:  Pediatr Pathol       Date:  1989

6.  FOXE1 association with differentiated thyroid cancer and its progression.

Authors:  Marissa Penna-Martinez; Friederike Epp; Heinrich Kahles; Elizabeth Ramos-Lopez; Nora Hinsch; Martin-Leo Hansmann; Ivan Selkinski; Frank Grünwald; Katharina Holzer; Wolf O Bechstein; Stefan Zeuzem; Christian Vorländer; Klaus Badenhoop
Journal:  Thyroid       Date:  2014-01-29       Impact factor: 6.568

7.  Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studies.

Authors:  D Delia; C Traversari; D Ballinari; G Cattoretti; E Fontanella; N Polli; G Della Porta
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

8.  Definitive identification of human T cells in formalin fixed paraffin wax embedded tissue.

Authors:  N D Francis; D M Clark; A W Boylston
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

9.  Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.

Authors:  Y R Mahida; S Patel; K Wu; D P Jewell
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

10.  Immunocytochemical staining of T and B lymphocytes in serous effusions.

Authors:  A K Ghosh; A I Spriggs; D Y Mason
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.